Clinical trial
Abbott BE TAVI Early Feasibility Study: Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System for the Treatment of Severe, Symptomatic Aortic Stenosis
NCT07116551 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Abbott BE TAVI Early Feasibility Study: Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System for the Treatment of Severe, Symptomatic Aortic Stenosis
- Lead sponsor
- Abbott Medical Devices
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- October 30, 2025
- Completion date
- June 30, 2031
- Enrollment
- 11 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
symptomatic severe aortic stenosis